Webinar: Theranostics of Tomorrow
Every year, World Cancer Day on February 4 unites the global community to raise awareness, advance education, and drive action toward improving cancer care. This year, we mark the occasion with a special webinar, Theranostics of Tomorrow, exploring how innovation is shaping the future of cancer diagnosis and treatment.
In this session, we will take a deep dive into the evolution of Theranostics — tracing its journey to where we are today and uncovering its transformative potential for the future. Our speaker will discuss its critical applications in cancer care and highlight how Siemens Healthineers is driving advancements along the entire Theranostics pathway.
Topics
Kevin Ulm
Kevin Ulm is the Global Head of Molecular Imaging Clinical Development at Siemens Healthineers. Kevin has spent over 30 years in the field of Nuclear Medicine. He began his career as a nuclear medicine technologist and entered the industry as an applications specialist. He has maintained a clinical focus while progressing through Siemens Molecular Imaging as a Product Manager, Product Sales Executive, Area Vice President, and his current position. Kevin has a passion for Theranostics and inspired by the intersection of innovation, science, and patient care.